Abstract

Immunoglobulin G1 (IgG1), a subclass of human serum antibodies, is the most widely used scaffold for developing monoclonal antibodies to treat human diseases. The composition of asparagine(N)297-linked glycans can modulate the binding affinity of IgG1 Fc to Fc γ receptors, but it is unclear how the structural modifications of N-glycan termini, which are distal from the binding interface, contribute to the affinity. Through atomistic molecular dynamics simulations of a series of sequentially truncated high-mannose IgG1 Fc glycoforms, we found that the C′E loop and the Cγ2-Cγ3 orientation are highly dynamic, and changes in N-glycan composition alter their conformational ensembles. High-mannose glycoform preferentially samples conformations that are more competent to FcγRIIIa binding, compared to the truncated glycoforms, suggesting a role of IgG1 Fc N-glycan in optimizing the interface with the Fc receptor for efficient binding. The trajectory analyses also reveal that the N-glycan has large amplitude motions and the carbohydrate moiety interconverts between Fc-bound and unbound forms, enabling enzymatic modification of the glycan termini.

Highlights

  • Immunoglobulin G1 (IgG1) is a subclass of human serum antibodies and is the most widely used platform for developing therapeutic monoclonal antibodies[6]

  • To explore both challenges, we investigated the impacts of different N-glycan compositions on the structure and dynamics of IgG1 Fc using atomistic molecular dynamics (MD) simulations of a series of sequentially truncated high-mannose IgG1 Fc glycoforms (Fig. 1B): (1) Fc with high-mannose N-glycans (Man8GlcNAc2, Fc-Man8), (2) Fc with five mannoses (Man5GlcNAc2, Fc-Man5), (3) Fc with a single core N-acetylglucosamine (Fc-GlcNAc), (4) aglycosylated Fc (Fc-N297Q), and (5) Fc with an asymmetric glycoform (Fc-Man8/N297Q)

  • High-mannose glycoform preferentially samples the C′E loop conformations and the Cγ2-Cγ3 orientations that are more competent to FcγRIIIa binding, compared to truncated glycoforms

Read more

Summary

Introduction

Immunoglobulin G1 (IgG1) is a subclass of human serum antibodies and is the most widely used platform for developing therapeutic monoclonal antibodies[6]. In addition to the biological significance of elucidating the role of N-glycans in Fc binding to FcγRs, proper N-glycan remodeling is required for the development of generation IgG1-based antibodies through Fc N-glycan optimization[22,23,24] To explore both challenges (antibody biology and engineering), we investigated the impacts of different N-glycan compositions on the structure and dynamics of IgG1 Fc using atomistic MD simulations of a series of sequentially truncated high-mannose IgG1 Fc glycoforms (Fig. 1B): (1) Fc with high-mannose N-glycans (Man8GlcNAc2, Fc-Man8), (2) Fc with five mannoses (Man5GlcNAc2, Fc-Man5), (3) Fc with a single core N-acetylglucosamine (Fc-GlcNAc), (4) aglycosylated Fc (Fc-N297Q), and (5) Fc with an asymmetric glycoform (Fc-Man8/N297Q). We report large amplitude motions of N-glycans, causing most carbohydrate moieties to be detached from the Fc polypeptide surface and making them accessible for enzymatic modifications of the glycan termini

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call